citibank Dow Jones Market News S&P 500 

Dow Futures Drop But a Blistering 9% Jump Awaits, Predicts Analyst

Dow Jones Industrial Average (DJIA) futures fell 136 points overnight after back-to-back gains. Wall Street analyst who nailed the March bottom sees another 9% upside in the stock market as momentum continues. Traders await a fresh round of jobless claims data, expected to come in at 1.8 million this week. The stock market looks set to open slightly lower on Thursday. Traders are taking a breather after a monster rally this week. Dow Jones Industrial Average (DJIA) futures were down 136 points this morning. This is likely just a cooling-off…

Read More
Dow Jones Market News 

Dow Futures Signal Big Rally Post-Memorial Day as Economy Shows Signs of Life

The Dow Jones Industrial Average rallied nearly 300 points in futures trading Monday night. Although the economy has likely plunged into recession, key indicators such as mortgage applications and travel bookings are up slightly. The Atlanta Fed’s GDP tracker estimates a second-quarter contraction of 41.9%. U.S. stock futures rose sharply Monday evening, as investors rallied behind early signs that the worst of the economic crisis had passed. Dow, S&P 500, Nasdaq Futures Climb Futures on all three major U.S. indexes broke to the upside Monday evening. Dow Jones futures rose…

Read More
Coronavirus Dow Jones Market News 

Dow Futures Slump as Covid-19 Hits Devastating Double Milestone

Dow Jones Industrial Average (DJIA) futures turned negative on Thursday morning. Coronavirus cases hit 5 million worldwide with a record 100,000 new daily cases. Focus shifts to Thursday’s jobless claims data which is expected to hit 39 million total claims since the crisis began. The Dow Jones continues its volatile week with a heavy slide in premarket futures trading. Investors remain nervous as the global coronavirus pandemic shows no signs of slowing down. The outbreak hit two devastating new milestones overnight: 5 million total worldwide cases. A record 100,000 new…

Read More
Anthony Fauci Coronavirus Donald Trump Dow Jones Market News Op-ed 

Billionaire Investors Aren’t the Only Ones Predicting a Stock Market Crash

Billionaire investors have warned that the stock market is overvalued. A majority of investors believe the next big market move will be down. A second wave of coronavirus cases and stock overvaluation could cause a market crash. A few days ago, billionaire investors warned that the U.S. stock market could crash as stocks are overvalued. Hedge fund manager Stanley Druckenmiller said that risk-reward for equity is the worst he has seen in his career. Markets appear too high with regard to uncertainty and likely bankruptcies looming on the horizon. Druckenmiller…

Read More
Donald Trump Dow Jones Market News Op-ed 

Trump Amps up the Hypocrisy in Tweet Torching Stock Market Bears

Donald Trump torched stock market bears on Wednesday, alleging they have an agenda. It’s amazing the president can say this with a straight face. The White House has been using the stock market for political gain since day one. President Donald Trump delivered one of his trademark unhinged tweetstorms on Wednesday, accusing hedge fund bosses of trying to manipulate the stock market for their own gain. This is extremely rich coming from a White House that does its best to pump the Dow Jones at every single opportunity. Straight-Faced Trump…

Read More
Coronavirus Dow Jones Market News Opinion 

Dow Futures Slump as Analysts Sound the Alarm on ‘Double-Dip’ Recession

Dow Jones futures fell by as much as 162 points Monday night. Analysts are warning of a “double-dip” recession if lockdown restrictions lead to a second wave of Covid-19 infections. Coronavirus has now infected more than 4.1 million people worldwide, according to official estimates. U.S. stock futures moved lower in overnight trading Monday, as investors anxiously monitored the gradual lifting of lockdown restrictions that have been in place since March. Many are welcoming the reopening of America, while others are concerned that a ‘too-hasty’ approach could have severe ramifications for…

Read More
Dow Jones Market News 

The Dow Is Eerily Calm – But Next Week Could Be Menacingly Volatile

The Dow Jones rallied on Friday as the U.S. stock market ended the week on a note of relative calm. President Trump signed another $484 billion stimulus package to support small businesses. Dow bulls are bracing for volatility, with a tidal wave of earnings, Q1 GDP, and the FOMC meeting all upcoming next week. The Dow Jones traded mostly sideways on Friday as Wall Street braced for what could be a week filled with menacing volatility as April gives way to May. Nearly half of the Dow’s 30 stocks will…

Read More
Dow Jones Market News 

Dow Futures Crawl Higher as Investors Cling to Main Street Cash Infusion

Dow futures movements suggest investor optimism about the new PPP cash infusion outweighs coronavirus fears. Leaked drug trial results from Gilead suggest there’s no quick-fix for coronavirus. Earnings are expected to continue to underscore the lack of visibility U.S. businesses have into their own futures. Wall Street uncertainty kept a lid on the stock market recovery Friday morning, but Dow futures pointed to a modestly higher opening as a fresh cash infusion from the U.S. government outweighed disappointing coronavirus updates. Investors’ muted response to mounting evidence of economic destruction can…

Read More
Coronavirus Dow Jones Gilead Sciences Market News Op-ed 

Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride

Gilead Sciences’ promising coronavirus drug made waves last week. Today, leaked WHO documents showed it flopped in a 237-person trial. Gilead was quick to downplay the trial as too small to be conclusive. But the firm wasn’t so conscientious about last week’s much smaller trial. The U.S. stock market ended Thursday flat after suffering a wild wobble midway through the session. The culprit? Every retail investor’s favorite coronavirus stock – Gilead Sciences. The Financial Times reported that the most promising coronavirus treatment – remdesivir – failed in a clinical trial….

Read More